A
Avivomed
Health Tech & Medtech · Minneapolis, United States · Founded 2020
Developing and commercializing next generation neuromodulaton technology platforms to treat patients suffering from chronic diseases MoreLess
Avivomed is a medical device company that develops neuromodulation therapies for chronic diseases. The company is focused on creating minimally invasive treatments that can improve the quality of life for patients with unmet clinical needs.
Avivomed's main product is a neuromodulation platform that uses electrical stimulation to modulate the nervous system. This technology can be used to treat a variety of conditions, including chronic pain, overactive bladder, and fecal incontinence. The company is currently in the development stage and has not yet commercialized its products.
Avivomed is a privately held company that was founded in 2021. The company has raised $3.2 million in Series A financing and is backed by a number of venture capital firms.
Keywords: neuromodulation, medical devices, chronic diseases, minimally invasive, electrical stimulation, chronic pain, overactive bladder, fecal incontinence, venture capital, series a
Company overview
Avivomed company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2020
- Headquarters
- Minneapolis, United States
- Employees
- 18
- Open positions
- None listed
- Dealroom signal
- 76.3
Valuation & funding
Avivomed funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Dec 2021 | $32M | $128M | Undisclosed | ↗ |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 18 |
| 2025 | 20 |
| 2024 | 16 |
Growth signals
Avivomed website traffic
Latest recorded traffic for Avivomed is 1K monthly website visits, up 212.5% over the last three months. Avivomed's team declined 10% over the past year.
Comparisons
Avivomed compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Avivomed's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Avivomed has talent and traffic
team presence
In the news
Latest news about Avivomed
Recent press, funding announcements, and product moves mentioning Avivomed — open to read from the original sources.
Market sentiment
What the market is saying about Avivomed
An AI-synthesized read of the highest-engagement posts about Avivomed on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Avivomed’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.